Bariatric surgery reduces costs for patients with type 2 diabetes
A Kaiser Permanente found that bariatric surgery reduced health care costs for adults with type 2 diabetes and obesity. The study was published in the Annals of Internal Medicine in February 2025. “The study shows that both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) help reduce ...
Featured News
Research leads to finding ways to improve outcomes for heart failure patients with chronic kidney disease
Research by physicians at the Kaiser Permanente Los Angeles Medical Center is helping patients with heart failure to transition more smoothly and safely to dialysis if they develop chronic kidney disease. ...
Medicaid enrollees less vaccinated during pregnancy across US
Most individuals in the United States who are pregnant are not getting the vaccines that could protect them — and their babies — from COVID-19, flu, and whooping cough, a new study shows. This is ...
Intensive blood pressure control and patients with chronic kidney disease
The benefits of intensive blood pressure shown in the Systolic Blood Pressure Intervention Trial (SPRINT) also helps patients with chronic kidney disease, according to new research led by Kaiser Permanente ...
Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19
July 23, 2021Hospitalized adults who have COVID-19 are more than 3 times as likely to develop a blood clot than adults who do not have COVID-19, according to new research from Kaiser Permanente Southern California and Kaiser Permanente Northern California. The study published July 20 in CHEST found Black patients as well as patients who had obesity, liver ...Read more...5 questions for … Dr. Erin Hahn
June 28, 2021Erin E. Hahn, PHD, MPH, is a health services researcher and implementation scientist. Her primary research interests are quality of care in oncology and the implementation of evidence-informed practices. She is particularly interested in the care of cancer survivors after their initial cancer treatment. Dr. Hahn joined the Department of Research & Evaluation as the ...Read more...Rates of heart failure deaths lower at Kaiser Permanente Southern California than U.S.
June 28, 2021A Kaiser Permanente Southern California research study found lower rates of heart failure mortality within the integrated health care system compared to the country as a whole. “In our study, we analyzed the overall rates of death attributable to heart failure throughout the state of California and United States, and then compared that to what we ...Read more...Kaiser Permanente Los Angeles Medical Center joins COVID-19 vaccine trial for children
June 11, 2021Kaiser Permanente Los Angeles Medical Center is participating in a clinical trial for the Moderna COVID-19 vaccine in children ages 6 months to less than 12 years. The KidCOVE study will evaluate the safety and efficacy of the Moderna COVID-19 vaccine (mRNA-1273), which is the same vaccine that was given Emergency Use Authorization (EUA) in December ...Read more...Kaiser Permanente Los Angeles Medical Center to study experimental stroke drug
June 4, 2021Kaiser Permanente Los Angeles Medical Center will conduct a multi-centered, randomized, Phase 3 research study to learn if the experimental drug recombinant Factor VIIa (rFVIIA), a protein that our body makes, can be used to decrease bleeding in the brain of patients who suffer sudden bleeding in the brain, also called intracerebral hemorrhage. The study entitled ...Read more...Marking Clinical Trials Day 2021 with gratitude
May 20, 2021On this day—May 20, 2021, aka Clinical Trials Day—we have more reasons than ever to celebrate the Kaiser Permanente Southern California clinical trials team. We began our COVID-19 clinical trials research with the remdesivir trial in March 2020. We were a top enroller in that study. Since then, our clinical trials program has participated in 9 ...Read more...Kaiser Permanente members have higher survival rate after cancer diagnosis
May 14, 2021Among insured cancer patients in Southern California, those who were diagnosed and treated at Kaiser Permanente, an integrated health care organization, had better survival rates, especially Black and Latinx patients, according to Kaiser Permanente research published in The American Journal of Managed Care. “Kaiser Permanente is committed to finding and addressing health care inequities,” said the ...Read more...COVID-19 outcomes are more severe for people of color
May 4, 2021A new Kaiser Permanente study published in Annals of Internal Medicine found that people of color were more likely to be hospitalized and to receive intensive-level care for COVID-19 compared to white patients even after adjusting for known health risk factors such as obesity, diabetes, and other conditions The study was among the first to show that these ...Read more...Celebrating our extraordinary nurses: During Nurses Week, all month, and throughout the year
May 4, 2021For National Nurses Week (May 6 to 12), Nurses Month, and Year of the Nurse, we celebrate the dedicated nurses who work in the Kaiser Permanente Southern California Department of Research & Evaluation. Nurses are a vital part of our research program. Most support clinical trials, where their relationship-building skills play an important part in helping ...Read more...5 questions for … Dr. Ana Florea
May 4, 2021Ana Florea, PhD, MPH, is an epidemiologist and post-doctoral research fellow with the Department of Research & Evaluation at Kaiser Permanente Southern California. She has special interests in vaccine safety and effectiveness, infectious diseases, cancer, and chronic kidney diseases. Currently, she is involved in projects studying shingles and Tdap vaccines. She works on projects involving ...Read more...